Complete coverage on

Fred Hassan

Latest Stories

Slashing jobs pays off ... if you're sitting in the executive suite.updated: Wed Sep 01 2010 07:59:00

A new report may add salt to the wounds of America's jobless. It seems many of their former bosses are profiting at their losses.

The Fred Factor: Fred Hassanupdated: Mon Apr 28 2008 03:44:00

If your drug company is on its death-bed, this is the man you want as your corporate doctor. He's Fred Hassan, the CEO of drug giant Schering-Plough. In the past 25 years, he has turned around his fair share of ailing pharmaceutical firms, including the recovery and subsequent 56 billion dollar sale of Pharmacia. He's so renowned within his industry that they coined a phrase for his brand of management: "The Fred Factor." Hassan tells The Boardroom's Maggie Lake how he is able to assess, diagnose and cure.

Fred Hassan, CEO, Schering-Ploughupdated: Mon Apr 28 2008 03:44:00

CNN's Maggie Lake gets advice from Fred Hassan, CEO of Schering-Plough, in ''The Boardroom.''

Fred Hassan profileupdated: Mon Apr 28 2008 03:43:00

Fred Hassan is chairman of the board and CEO of Schering-Plough Corporation.

CNNMoney: Schering stock jumps on earnings winupdated: Tue Feb 12 2008 12:00:00

Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.

Fortune: Schering CEO in the hot seatupdated: Mon Feb 11 2008 14:00:00

As Schering-Plough unveils full-year financial results for 2007 tomorrow, CEO Fred Hassan is likely to be peppered with questions about how he managed a recently released study of embattled cholesterol drug, Vytorin.

CNNMoney: Schering settles sales probe for $435 millionupdated: Tue Aug 29 2006 11:03:00

Schering-Plough said Tuesday it settled a criminal investigation into its sales practices and agreed to pay $435 million in fines and damages.

CNNMoney: Schering-Plough's cholesterol problemupdated: Tue Aug 08 2006 09:46:00

Drugmaker Schering-Plough may have wowed investors with strong second-quarter earnings - but the company has a cholesterol problem.

Fortune: DOESN'T ANYONE KNOW HOW TO RUN A DRUG COMPANY? updated: Mon Apr 18 2005 00:01:00

THE TYPICAL FORTUNE 500 COMPANY rarely has trouble filling the job when a CEO retires (or gets fired). To wit: Less than two months after Carly Fiorina's ouster, Hewlett-Packard announced NCR CEO M...

Fortune: Is It Too Late To Save Schering? CEO Fred Hassan has a hair-raising task: fixing the drugmaker's problems in the updated: Mon Sep 15 2003 00:01:00

Fred Hassan talks like a professional therapist. Not in a cooing, I-feel-your-pain, Oprah sort of way, but with a gentle authority that, no matter how harsh the pronouncement, is still soothing. Sc...

Fortune: A TEMPTING DRUG DEAL HAS WALL STREET OVERDOSED ON THE BAD NEWS AT PHARMACIA & UPJOHN?updated: Mon Jun 09 1997 00:01:00

A tired product mix hamstrung by slow sales growth. A CEO who quits without warning. Repeated earnings disappointments. And a sprawling corporate empire with executives in four countries who speak ...

We recommend